Status:
UNKNOWN
Cervical Cancer Screening With Human Papillomavirus Testing
Lead Sponsor:
International Agency for Research on Cancer
Conditions:
CIN3
CIN2
Eligibility:
FEMALE
30-64 years
Brief Summary
HPV testing for primary cervical cancer screening of women over 30 years of age is likely to become the standard of care in the near future in many areas of the world. Its high sensitivity can signifi...
Detailed Description
The study will be conducted in several Latin American countries. Currently, the study has started in one site in Colombia and soon another site in Mexico will start. In each participating center, wome...
Eligibility Criteria
Inclusion
- Aged 30-64 years
- Mentally competent to be able to understand the consent form
- Able to communicate with study staff
- Physically able to have a pelvic exam
Exclusion
- Reporting no previous sexual activity
- History of cervical cancer
- Previous treatment for cervical pre-cancer in the last six months
- Hysterectomy
- Plans to move out of the study area in the next 12 months
- Screened for cervical cancer in the last 12 months (depending on local regulations)
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT01881659
Start Date
May 1 2013
End Date
December 31 2023
Last Update
March 14 2023
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopsital de Clinicas
Buenos Aires, Argentina
2
Insituto Malbran - Hospital Posadas
Buenos Aires, Argentina
3
Universidad San Francisco Xavier de Chuquisaca
Sucre, Bolivia
4
National Cancer Institute of Colombia
Bogotá, Colombia